In the realm of pathology, particularly its role in cancer care, we’ve witnessed significant evolution. In the past, our tools were limited to microscopes and specialized stains. The advent of Immunohistochemistry (IHC) was a pivotal moment, enhancing diagnostic and treatment capabilities.

However, the landscape of cancer treatment has shifted dramatically. We’ve moved from the era of one-size-fits-all chemotherapy to the precision medicine era. It’s now evident that each tumor is a unique entity with its distinct genetic and molecular subtypes. Identifying the driver mutations responsible for cancer growth has become the focal point of cancer research.

Lung cancer serves as a prime example of this paradigm shift. At Sadguru Cancer Hospital, we’re acutely aware of the significance of these advances in Oncopathology.



Scroll to Top